吲哚美辛抑制大鼠子宫内膜异位症微血管形成的实验研究

《吲哚美辛抑制大鼠子宫内膜异位症微血管形成的实验研究》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、吲哚美辛抑制大鼠子宫内膜异位症微血管形成的实验研究摘要：目的研究吲哚美辛对大鼠子宫内膜异位症微血管的影响。方法建立大鼠子宫内膜异位症模型。随机分组:治疗组喂服吲哚美辛(5mg•kg-1•d-1),对照组给予相应体积溶剂(0.2%二甲亚砜-生理盐水溶液)。4w后处死动物，采用免疫组化法检测子宫内膜组织中微血管密度(MVD)及血管内皮生长因子(VEGF)的表迗，兔抗大鼠CD34标记微血管。结果子宫内膜体积治疗组和对照组MVD分别为15±3和27±5(P参考文献：[1]ShifrenJL,TsengJF,ZaloudekCJ,etal.Ovari

2、ansteroidregulationofvascularendothelialgrowthfactorinthehumanendometrium：implicationsforangiogenesisduringthemenstrualcycleandinthepathogenesisofendometriosis[J].TheJournalofclinicalendocrinologyandmetabolism,1996,81(8):3112-3118.[2]XuXF,GuWZ,WuXL,etal.Fetalpulmonaryvascu

3、larremodelinginaratmodelinducedbyhypoxiaandindomethacin[J].JournalofMaternal-FetalandNeonatalMedicine,2011,24(1)：172—182.[1]辛志敏，谢青贞，曹路敏，等.放置宫内节育器对子宫内膜血管内皮生长因子及其激酶受体表迖及微血管密度变化的影响[J].中华妇产科杂志，2004,39(11):771-775[2]ZulfikarogluE,K?l?cS,IslimyeM,etal.Efficacyofanti-tumornecrosi

4、sfactortherapyonendometriosisinanexperimentalratmodel[J].Archivesofgynecologyandobstetrics,2011,283(4):799-804.[3]GusetG,CostiS,LazarE,etal.Expressionofvascularendothelialgrowthfactor(VEGF)andassessmentofmicrovasculardensitywithCD34asprognosticmarkersforendometrialcarcinom

5、a[J].RomJMorpholEmbryol,2010,51(4)：677-682.[4]FerraraN.Bindingtotheextracellularmatrixandproteolyticprocessing：twokeymechanismsregulatingvascularendothelialgrowthfactoraction[J].Molecularbiologyofthecell,2010,21(5):687-690.[5]BatesD0.Vascularendothelialgrowthfactorsandvasc

6、ularpermeability[J].Cardiovascularresearch,2010,87(2)：262-271.[6]MahdianS,ShahhoseiniM,NooriE,etal.ExpressionprofileofMIF,CD74andCOX-2inpatientswithendometriosisandnormalendometriuminmenstrualcycle[JLIranianJournalofReproductiveMedicine,2013.3(21)48-49[1]EbertAD,BartleyJ,D

7、avidM.Aromataseinhibitorsandcyclooxygenase-2(COX-2)inhibitorsinendometriosis：Newquestions-oldanswers?[J].EuropeanJournalofObstetrics&GynecologyandReproductiveBiology,2005,4(8):144-150.[2]JonesMK,WangH,PeskarBM,etal.Inhibitionofangiogenesisbynonsteroidalanti-inflammatorydru

8、gs：insightintomechanismsandimplicationsforcancergrowthandulcerhealing[J].NatMed,1999,5(12